G1 Therapeutics, Inc. (GTHX)
NASDAQ: GTHX · IEX Real-Time Price · USD
2.540
+0.010 (0.40%)
Jun 21, 2024, 1:00 PM EDT - Market open

G1 Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019 2018 - 2017
Market Capitalization
133158233434684993
Upgrade
Market Cap Growth
--32.14%-46.33%-36.57%-31.09%39.49%
Upgrade
Enterprise Value
114132170295504733
Upgrade
PE Ratio
-7.37-3.30-1.58-2.93-6.90-8.11
Upgrade
PS Ratio
1.581.924.5413.7915.11-
Upgrade
PB Ratio
4.794.473.393.033.863.89
Upgrade
P/FCF Ratio
-12.40-4.12-1.80-3.29-8.19-9.71
Upgrade
P/OCF Ratio
-12.40-4.12-1.81-3.29-8.17-9.98
Upgrade
EV/Sales Ratio
1.361.603.329.3611.14-
Upgrade
EV/EBITDA Ratio
-11.48-3.84-1.26-2.07-5.28-6.00
Upgrade
EV/EBIT Ratio
-11.17-3.78-1.26-2.06-5.25-5.99
Upgrade
EV/FCF Ratio
-11.39-3.43-1.32-2.23-6.03-7.17
Upgrade
Debt / Equity Ratio
1.701.581.200.570.160.04
Upgrade
Debt / EBITDA Ratio
-2.61-1.63-0.61-0.58-0.29-0.08
Upgrade
Debt / FCF Ratio
-2.59-1.46-0.64-0.62-0.33-0.09
Upgrade
Quick Ratio
2.363.204.408.238.8713.64
Upgrade
Current Ratio
2.943.875.048.829.2313.71
Upgrade
Asset Turnover
0.670.590.270.120.180
Upgrade
Interest Coverage
-2.08-3.47-12.98-30.59-54.03-
Upgrade
Return on Equity (ROE)
-74.80%-106.00%-209.90%-76.00%-49.10%-41.00%
Upgrade
Return on Assets (ROA)
-24.30%-34.00%-77.70%-54.80%-39.80%-38.10%
Upgrade
Return on Capital (ROIC)
-30.51%-43.30%-89.96%-63.18%-47.04%-48.68%
Upgrade
Earnings Yield
-23.04%-30.34%-63.33%-34.17%-14.50%-12.33%
Upgrade
FCF Yield
-13.69%-24.25%-55.42%-30.43%-12.21%-10.30%
Upgrade
Buyback Yield / Dilution
-1.01%-18.58%-4.01%-10.73%-1.01%-12.55%
Upgrade
Total Shareholder Return
-1.01%-18.58%-4.01%-10.73%-1.01%-12.55%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).